A recent study has raised concerns about a widely used blood pressure medication called Calcium Channel Blockers (CCBs).
2d
Clinical Trials Arena on MSNAstraZeneca’s $1bn hypoparathyroidism drug achieves success at Phase IIIAstraZeneca acquired the hypoparathyroidism therapy eneboparatide as part of a buyout of Amolyt Pharma in July 2024.
Blocking calcium could have a beneficial effect on the heart’s ability to regenerate myocardium in patients with ischemic heart failure, according to a new study published online in npj Regenerative ...
3don MSN
Find insights on AstraZeneca, Incyte and more in the latest Market Talks from the health-care sector.
Discover 7 tips to lower high blood pressure naturally, from the DASH diet to stress management techniques that can help you ...
The National Agency for Food and Drug Administration and Control has warned fruit dealers and sellers against using calcium carbide in fruit ripening for commercial purposes. The warning was made ...
A physician in Chattanooga, Tenn., and his practice in Ringgold, Ga., will pay $700,000 to resolve allegations that they ...
High prevalence of polypharmacy and unsafe self-medication among older adults in Indian urban communities, highlighting the need for interventions.
Healthy or risky? Many people take dietary supplements daily to overcome their body’s nutritional needs. However, you need to ...
I developed a case of a bigeminy heartbeat. My cardiologist prescribed metoprolol. At about the same time, I had reduced my intake of magnesium from ...
8d
The Brighterside of News on MSNLife changing hypertension medication also extends life expectancyScientists have identified a widely prescribed hypertension drug as a potential key to extending lifespan and slowing aging.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results